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Background.Multifocal osteosarcoma is usually described as the occurrence of the tumour at two or more sites in a patient without
pulmonary metastases and may be synchronous or metachronous. Case report. A previously well 21-year old male, who presented
with a swollen, painful right knee with no history of trauma, was found to have a high-grade osteosarcoma of the distal tibia
and proximal femur. He underwent resection and prosthetic replacement of the distal femur and proximal tibia and remains well
19 months after diagnosis. Discussion. Multifocal osteosarcoma is a rare condition with a poor prognosis. There is debate about
whether it represents multiple primary tumours or metastatic disease.
Copyright © 2006 V. A. Currall and J. H. Dixon. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
BACKGROUND
Multifocal or multicentric osteosarcoma was ﬁrst described
bySilverman[1].Itisusuallydeﬁnedastheoccurrenceofthe
tumour at two or more sites in a patient without pulmonary
metastases [2–4] and may be synchronous (more than one
lesion at presentation) or metachronous (new tumours de-
velopingaftertheinitialtreatment).Wepresenthereacaseof
synchronous multifocal osteosarcoma with an unusual man-
agement dilemma and review of the literature.
CASE REPORT
The patient was a ﬁt and well 21-year old man who initially
presented to his GP with a painful right knee with no history
of trauma. This was diagnosed as a soft tissue injury, but, six
monthslater,henoticedaswellinginhisrightproximaltibia.
Ap l a i nx-ray showed a pathological fracture of the proximal
tibia (Figure 1) and he was referred to the regional sarcoma
centre via his local fracture clinic.
His initial investigations of blood tests, chest x-ray, and
abdominal ultrasound showed no abnormalities, but MRI
rightkneeclearlydemonstratedanosteosarcomaintheprox-
imal tibia with further lesions in the distal femur (Figure 2).
Abiopsy oftheproximaltibiallesionconﬁrmedthediag-
nosis of high-grade intramedullary osteosarcoma (Figure 3).
Neoadjuvant chemotherapy of ﬁve cycles of doxorubicin and
cisplatin was commenced.
The preoperative CT chest was clear and a further biopsy
of both the distal tibial and proximal femoral lesions con-
ﬁrmed high-grade intramedullary osteosarcoma with necro-
sis. Because of this good response to chemotherapy, the de-
cision was made to conserve the leg. Therefore, six months
after diagnosis, the patient underwent resection of the right
proximal tibia and distal femur with prosthetic replacement
(Figure 4). The ﬁnal histology showed necrotic bone tumour
in the femoral and tibial lesions.
The patient underwent three months of postoperative
chemotherapy and he remains clinically well. Nine months
later, he was walking unaided and with knee ﬂexion in ex-
cess of 90 degrees. There are no radiological signs of recur-
rence, either on plain x-ray or on MRI. A further MRI scan
is planned shortly.
DISCUSSION
Synchronous multifocal osteosarcoma is a rare condition,
with a reported incidence of 1% to 3% [5–7]. There is much
debate in the literature on whether it represents multiple
primary tumours or metastatic disease. Initially, the case
for multiple primary tumours was favoured [8, 9], because
there was no obvious route for spread if the lungs were free2 Sarcoma
Figure 1: Pathological fracture of right proximal tibia.
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Figure 2: MRI right leg, showing osteosarcoma of proximal tibia
with further lesions in the distal femur.
of tumour, which was thought to rule out haematogenous
metastasis. More recently, the report of cases related to p53
mutations[10]andretinoblastoma[11]mightsuggestapos-
sible mechanism for multiple primary tumours.
However, more recent reviews conclude that the case for
multicentric osteosarcoma as a metastatic process is almost
proven [2, 12]. The reasons for this include the presence of a
large “dominant” lesion, usually that leading to presentation,
asinourcase,whichcouldbetheprimarytumour.Enneking
and Kagan [13] suggest that bone-to-bone metastases could
occur via a similar mechanism to that of prostate cancer via
Batson’s venous plexus [14], or intraosseous embolisation
through marrow sinusoids. Alternatively, Hatori et al have
demonstrated lymphatic spread to the lungs, giving another
possible route [15]. It has also been noted that early case
Figure 3: Biopsy of proximal femoral lesion showing high-grade
intramedullary osteosarcoma.
Figure 4: Postoperative x-rays showing prosthetic replacement.
reports may well have underestimated the incidence of pul-
monary metastasis, as the diagnosis of these relied on x-ray
only, rather than CT scan [4]. Finally, there has been a corre-
lation demonstrated between the responses of the dominant
and other lesions to chemotherapy, which again points to a
primary tumour and metastases [16].
The most commonly quoted classiﬁcation is that of
Amstutz [3], in which types I and II are synchronous
(child/adolescent high grade and adult low grade, resp) and
type III metachronous (subdivided into IIIa and b—early
and late). Mahoney suggested a similar four-category system
(A to D) ten years later [17]. They agree that the progno-
sis for synchronous multifocal osteosarcoma is poor, with
mean survival of six months for type I/A and a slightly better
range of 5 to 72 months for type II/B. Unfortunately, despiteV. A. Currall and J. H. Dixon 3
advances in both surgery and chemotherapy, more recent re-
ports do not suggest a more favourable prognosis [7, 16, 18],
with a mean survival of 27 months found by Bacci et al, al-
though one patient was disease-free at nine years [16].
So what does this mean for our case? His has been a fairly
standard course so far, although it could be argued that the
pathological fracture predisposed to his multifocal presenta-
tionviaeitherthevenousorsinusoidroutes.Heremainsalive
and disease-free 19 months afterdiagnosis and willhopefully
be one of the few who stays that way.
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